Overview
Leukemic infiltration refers to the presence of leukemic cells within tissues or organs, often complicating the diagnosis and management of leukemia by affecting multiple systems beyond the hematopoietic compartment. 15Diagnosis
Histopathological Examination: Essential for confirming leukemic infiltration, typically involving biopsy samples stained with hematoxylin and eosin (H&E) or specialized stains like immunohistochemistry. 15
Flow Cytometry: Recommended for identifying specific leukemic cell markers and subtypes.
Bone Marrow Aspiration and Biopsy: Often necessary to assess the extent of bone marrow involvement.
Imaging Studies: Useful for assessing organ involvement, such as CT or MRI scans.Management
Chemotherapy: First-line treatment tailored to the specific type of leukemia (e.g., anthracyclines, cytarabine, targeted therapies). Specific drug classes and doses vary by leukemia subtype and patient condition.
Supportive Care: Includes management of cytopenias, infection prophylaxis, and symptom control.
Targeted Therapies: Used in specific subtypes where molecular targets are identified (e.g., tyrosine kinase inhibitors in CML).Special Populations
Pregnancy: Management requires careful consideration of teratogenic risks and balancing maternal and fetal health; specific guidelines are sparse in provided abstracts. 13
Pediatrics: Treatment protocols often differ, emphasizing less toxic agents and long-term developmental outcomes; detailed protocols not covered in abstracts.
Elderly: Treatment strategies may be modified due to comorbidities and reduced tolerance to intensive therapies; specific recommendations vary 25.
Comorbidities: Presence of other diseases influences treatment selection and intensity; tailored approaches are necessary but not extensively detailed in abstracts.Key Recommendations
Implement regular histopathological audits to maintain diagnostic accuracy and identify errors in reporting leukemic infiltration (Evidence: Expert opinion) 5
Ensure adequate exposure of trainees to diverse surgical pathology cases, including those with leukemic infiltration, to enhance diagnostic skills (Evidence: Expert opinion) 1
Periodically update hematology laboratory guidelines to reflect current best practices, especially in areas with limited evidence (Evidence: Moderate) 3References
1 Sabageh D, Daramola AO, Rotimi O. Histopathology practice and training in Nigeria – a model. Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria 2016. link
2 . Note of concern. The American journal of pathology 2015. link
3 Hayward CP, Moffat KA, George TI, Proytcheva M. Assembly and evaluation of an inventory of guidelines that are available to support clinical hematology laboratory practice. International journal of laboratory hematology 2015. link
4 Vollmer RT. Analysis of turnaround times in pathology: an approach using failure time analysis. American journal of clinical pathology 2006. link
5 Cree IA, Guthrie W, Anderson JM, Holley MP, Hopwood D, Sanders DS et al.. Departmental audit in histopathology. Pathology, research and practice 1993. link80335-3)